Definium Therapeutics, Inc. Capital Reinvestment Ratio

Latest as of June 2019: 0.00x

Definium Therapeutics, Inc. capital reinvestment ratio. Definium Therapeutics, Inc. (DFTX) has a Capital Reinvestment Ratio of 0.00x as of June 2019, meaning it reinvests 0% of its operating cash flow ($24.19K) in capital expenditures ($0.11). Check DFTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$24.19K

USD

Capital Expenditures

$0.11

USD

Data as of

Jun 2019

Most recent filing

Definium Therapeutics, Inc. Capital Reinvestment Ratio by Year (None–None)

Definium Therapeutics, Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Definium Therapeutics, Inc. (DFTX) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow